BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38888739)

  • 1. Comparison of intra- and inter-reader agreement of abbreviated versus comprehensive MRCP for pancreatic cyst surveillance.
    Huang C; Prabhu V; Smereka P; Vij A; Anthopolos R; Hajdu CH; Dane B
    Abdom Radiol (NY); 2024 Jun; ():. PubMed ID: 38888739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-reader agreement of interpretation of radiological course of bile duct changes between serial follow-up magnetic resonance imaging/3D magnetic resonance cholangiopancreatography of patients with primary sclerosing cholangitis.
    Grigoriadis A; Morsbach F; Voulgarakis N; Said K; Bergquist A; Kartalis N
    Scand J Gastroenterol; 2020 Feb; 55(2):228-235. PubMed ID: 32024405
    [No Abstract]   [Full Text] [Related]  

  • 3. Agreement among Magnetic Resonance Imaging/Magnetic Resonance Cholangiopancreatography (MRI-MRCP) and Endoscopic Ultrasound (EUS) in the evaluation of morphological features of Branch Duct Intraductal Papillary Mucinous Neoplasm (BD-IPMN).
    Uribarri-Gonzalez L; Keane MG; Pereira SP; Iglesias-García J; Dominguez-Muñoz JE; Lariño-Noia J
    Pancreatology; 2018 Mar; 18(2):170-175. PubMed ID: 29338919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging short protocols for intraductal papillary mucinous neoplasm (IPMN) surveillance: The time has come.
    D'Onofrio M; Geraci L; De Robertis RL; Cardobi N; Balduzzi A; Tomaiuolo L; Bardhi E; Faccioli N; Aluffi G; Marchegiani G; Salvia R
    Dig Liver Dis; 2024 Apr; ():. PubMed ID: 38614923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI follow-up for pancreatic intraductal papillary mucinous neoplasm: an ultrashort versus long protocol.
    Johansson K; Mustonen H; Nieminen H; Haglund C; Lehtimäki TE; Seppänen H
    Abdom Radiol (NY); 2022 Feb; 47(2):727-737. PubMed ID: 34923598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Feasibility of Abbreviated Magnetic Resonance With Breath-Hold 3-Dimensional Magnetic Resonance Cholangiopancreatography for Surveillance of Pancreatic Intraductal Papillary Mucinous Neoplasm.
    Kang HJ; Lee DH; Lee JM; Yoo J; Weiland E; Kim E; Son Y
    Invest Radiol; 2020 May; 55(5):262-269. PubMed ID: 32073419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic Cyst Size Measurement on Magnetic Resonance Imaging Compared to Pathology.
    Jeong D; Morse B; Polk SL; Chen DT; Li J; Hodul P; Centeno BA; Costello J; Jiang K; Machado S; El Naqa I; Farah PT; Huynh T; Raghunand N; Mok S; Dam A; Malafa M; Qayyum A; Fleming JB; Permuth JB
    Cancers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of gadolinium for identifying the malignant potential of pancreatic cystic lesions.
    Kierans AS; Gavlin A; Wehrli N; Flisnik LM; Eliades S; Pittman ME
    Abdom Radiol (NY); 2022 Apr; 47(4):1351-1359. PubMed ID: 35195765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP.
    Sahani DV; Kadavigere R; Blake M; Fernandez-Del Castillo C; Lauwers GY; Hahn PF
    Radiology; 2006 Feb; 238(2):560-9. PubMed ID: 16436817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidental pancreatic cystic lesions: comparison between CT with model-based algorithm and MRI.
    Ippolito D; Maino C; Pecorelli A; De Vito A; Riva L; Talei Franzesi C; Sironi S
    Radiography (Lond); 2021 May; 27(2):554-560. PubMed ID: 33281035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer detection with a non-contrast MR protocol: is it reliable?
    Maio F; Pasqualino V; Bertana L; Venturini S; Cantoni V; Fusaro M; Morana G
    Radiol Med; 2023 Sep; 128(9):1035-1046. PubMed ID: 37515631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas.
    Yoon LS; Catalano OA; Fritz S; Ferrone CR; Hahn PF; Sahani DV
    J Comput Assist Tomogr; 2009; 33(3):363-8. PubMed ID: 19478628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic value of abbreviated MRI protocol in the surveillance of Branch-Duct intraductal papillary mucinous neoplasm.
    Malekzadeh S; Cannella R; Fournier I; Hiroz P; Mottet C; Constantin C; Widmer L
    Eur J Radiol; 2024 Jun; 175():111455. PubMed ID: 38608499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT.
    Do RK; Katz SS; Gollub MJ; Li J; LaFemina J; Zabor EC; Moskowitz CS; Klimstra DS; Allen PJ
    AJR Am J Roentgenol; 2014 Nov; 203(5):973-9. PubMed ID: 25341134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver Variability and Diagnostic Performance in Predicting Malignancy of Pancreatic Intraductal Papillary Mucinous Neoplasm with MRI.
    Choi SY; Min JH; Kim JH; Park HJ; Kim YY; Han YE; Bae SH; Lee JH; Choi YH; Moon JE
    Radiology; 2023 Jul; 308(1):e222463. PubMed ID: 37489989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of compressed sensing to 3D magnetic resonance cholangiopancreatography for the evaluation of pancreatic cystic lesions.
    Furlan A; Bayram E; Thangasamy S; Barley D; Dasyam A
    Magn Reson Imaging; 2018 Oct; 52():131-136. PubMed ID: 29859947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic MRI for the surveillance of cystic neoplasms: comparison of a short with a comprehensive imaging protocol.
    Pozzi-Mucelli RM; Rinta-Kiikka I; Wünsche K; Laukkarinen J; Labori KJ; Ånonsen K; Verbeke C; Del Chiaro M; Kartalis N
    Eur Radiol; 2017 Jan; 27(1):41-50. PubMed ID: 27246720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis.
    Grigoriadis A; Imeen Ringe K; Bengtsson J; Baubeta E; Forsman C; Korsavidou-Hult N; Rorsman F; Nilsson E; Kartalis N; Bergquist A
    JHEP Rep; 2022 Dec; 4(12):100595. PubMed ID: 36444388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does secretin stimulation add to magnetic resonance cholangiopancreatography in characterising pancreatic cystic lesions as side-branch intraductal papillary mucinous neoplasm?
    Purysko AS; Gandhi NS; Walsh RM; Obuchowski NA; Veniero JC
    Eur Radiol; 2014 Dec; 24(12):3134-41. PubMed ID: 25100335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-reader agreement of pancreatic adenocarcinoma resectability assessment with photon counting versus energy integrating detector CT.
    Kim J; Mabud T; Huang C; Lloret Del Hoyo J; Petrocelli R; Vij A; Dane B
    Abdom Radiol (NY); 2024 Apr; ():. PubMed ID: 38630314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.